Manufacturer
INTAS PHARMACEUTICALS LIMITED
Contents
Azacitidine
Indication
Myelodysplastic disease.
Instruction
Administer via Subcutaneous Injection or IV Infusion by Healthcare Personnel.
Drug interaction
Not known.